> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Approves Celexa Safety Labeling Changes
- URL: https://www.fdaweb.com/fda-approves-celexa-safety-labeling-changes/
- Published: 2022-02-09T12:00:00.000Z
- Updated: 2026-09-14T17:31:56.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5151128

FDA has approved several safety-related labeling changes for Allergan’s Celexa (citalopram hydrobromide), a selective serotonin reuptake inhibitor indicated for treating depression. *Psychiatric Times* [reports](https://www.psychiatrictimes.com/view/fda-announces-safety-labeling-changes-to-celexa?ref=fdaweb.com) the changes include new dosage recommendations and Warnings for a higher risk of adverse reactions in pediatric and geriatric populations. The labeling also includes Warnings for heightened risk of sexual dysfunction in both male and female patients.